(Q37229923)

19 August 2017

1 reference

title

Cost-effectiveness of varicella vaccination programs: an update of the literature (English)

1 reference

cost-effectiveness analysis

19 August 2017

1 reference

4

Maarten J Postma

1 reference

19 August 2017

Mark H Rozenbaum

1

1 reference

19 August 2017

Albert Jan van Hoek

series ordinal

2

1 reference

19 August 2017

Stefan Vegter

series ordinal

3

1 reference

19 August 2017

language of work or name

1 reference

1 August 2008

1 reference

Expert Review of Vaccines

19 August 2017

1 reference

19 August 2017

7

1 reference

19 August 2017

6

1 reference

19 August 2017

753-782

1 reference

Varicella-zoster virus infection in Australia

19 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

The epidemiology of varicella and its complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Varicella vaccine: the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Live attenuated varicella virus vaccine. Efficacy trial in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Metaanalysis of vaccine effectiveness in varicella outbreaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Modelling the impact of immunization on the epidemiology of varicella zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Varicella vaccination in England and Wales: cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

The incidence of herpes zoster in a United States administrative database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Incidence of herpes zoster, 1997-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Effects of varicella vaccination on herpes zoster incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Economic evaluations of varicella vaccination programmes: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

A cost benefit analysis of routine varicella vaccination in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Instituting a routine varicella vaccination program in Canada: an economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

The cost-effectiveness of varicella vaccine programs for Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

An economic analysis of varicella vaccination for health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Cost effectiveness of vaccination strategies in adults without a history of chickenpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Impact of varicella vaccination on health care utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

[Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Varicella vaccination in Italy : an economic evaluation of different scenarios

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Cost-effectiveness of varicella vaccination of healthcare workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Cost containment analysis of childhood vaccination against varicella in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Discounting health effects in pharmacoeconomic evaluations: current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Cost-effectiveness of a routine varicella vaccination program for US children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Reactogenicity to a live attenuated varicella vaccine in Canadian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Vaccination against Herpes Zoster and Postherpetic Neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Health economic methodology illustrated with recent work on Chlamydia screening: the concept of extended dominance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

21 January 2018

Varicella Vaccine Update

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

Costs And Benefits Of Routine Varicella Vaccination In German Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

An economic evaluation of varicella vaccination in Italian adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.753

21 January 2018

Identifiers

DOI

10.1586/14760584.7.6.753

1 reference

19 August 2017

1 reference